CompaniesArmgo Pharma

Armgo Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

15

By Phase

PHASE2: 1PHASE1: 1

By Status

TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
NCT04141670
Hover over trial bars to see details

Recent Trials

NCT05122975Lead Sponsor
Treatment of an Inherited Ventricular Arrhythmia
PHASE2Terminated
8 participants
Started: Aug 1, 2023 · Completed: Apr 1, 2024
NCT04141670Lead Sponsor
S 48168 (ARM 210) for the Treatment of RYR1-related Myopathies (RYR1-RM)
PHASE1Completed
7 participants
Started: Aug 25, 2020 · Completed: Jul 30, 2023
Funding History (1)
D
Aug 24, 2011
Filing